HSIC HENRY SCHEIN INC Insider Trading

Director William K Daniel purchases 10,000 shares as stock trades well below its 52-week high; repeat buyer with proven timing.

William K Daniel, a director of Henry Schein, purchased shares while the stock trades substantially below its 52-week high, extending a pattern of deliberate accumulation he established earlier in the prior year. His previous open-market purchase resulted in meaningful gains over both near and longer-term periods, and the stock has now pulled back further from those levels—Daniel is buying into additional weakness. The company itself remains solidly profitable with strong revenue growth, giving the director a financially healthy business to buy into rather than a turnaround play. This is Daniel's second open-market purchase in the 36-month window, indicating a consistent orientation toward accumulating shares at depressed valuations rather than selling, which aligns with his track record of well-timed prior purchases.

CEO Stanley M. Bergman sells 43,812 shares of Henry Schein for $3,562,353.72 on 2026-03-02 at $81.31

Stanley M. Bergman, Chairman and CEO of Henry Schein, executed two separate sales on 2026-03-02 totaling 43,812 shares for $3,562,353.72 at a blended price of $81.31, reducing his holdings by 10.2% from 427,615 to 383,803 shares. His cross-ticker track record shows 100.00% well-timed sells with a -2.1% average 90-day return, indicating his prior sales have consistently preceded stock declines; however, at Henry Schein specifically, his 2 prior measurable sales (2023-12-26) both showed -3.0% 90-day returns. The stock currently trades at $80.21, down 3.8% from its 52-week high of $83.35, while trading up 6.3% over the past 30 days and up 10.1% over the past 90 days. This sale occurs against a backdrop of solid fundamentals: $3.3B quarterly revenue, +4.0% annual growth, P/E of 23.05, and $9.2B market cap, making the timing signal unclear without additional context on the gap between transaction price ($81.31) and current valuation.

Chairman/CEO Bergman sells 49,131 shares at blended $81.06 for $4.0M; 4 prior HSIC sales each showed negative 90d returns

Stanley M. Bergman, Chairman and CEO, executed 3 separate sales on 2026-02-26 and 2026-02-27, totaling 49,131 shares for $3,982,332.72 at a blended average price of $81.06, reducing his holdings from 358,223 shares to 309,092 shares. His prior trading history at Henry Schein shows a consistent pattern: all 4 prior open-market sales at HSIC occurred in December 2023 and each exhibited negative 90-day returns (-3.0%, -3.0%, -1.3%, -1.3%), resulting in a 100% well-timed rate at the 90-day mark. The current stock price of $82.39 stands near the 52-week high of $83.35, having risen 9.7% over the past 30 days and 10.5% over 90 days. Given this insider's historical accuracy in selling before subsequent declines at this specific ticker, the timing of these new sales near all-time highs warrants attention to see if the pattern repeats.

Director Daniel William K purchases 10,000 shares of HSIC at $67.08; stock down -19.3% from 52-week high of $81.91

Director Daniel William K purchased 10,000 shares at $67.08 on 2025-08-07, establishing a new 10,000 share position with no prior holdings. The purchase occurs at a price that is -19.3% below the 52-week high of $81.91 and reflects a -10.0% decline over the past 30 days. HSIC trades at a P/E of 20.59 with recent quarterly revenue of $3.2B and annual revenue growth of +2.7%, indicating a moderately valued healthcare distributor in a modest growth phase. The director's acquisition represents a material commitment of capital (total value $670.8K) in a depressed price environment relative to recent highs, though without prior transaction history at this ticker we cannot establish whether this reflects a systematic pattern or isolated activity.

EVP & COO Ettinger sold 12,240 shares ($918,000) at $75.00; holds 87,706 post-transaction; stock at $73.73 current (-8.5% from high)

Ettinger Michael S, EVP & Chief Operating Officer, sold 12,240 shares of HENRY SCHEIN INC at $75.00 on 2024-11-18 for a total of $918,000.00, representing a 12.2% reduction in his holdings. His remaining position is 87,706 shares. The current stock price of $73.73 is -8.5% from the 52-week high of $80.57, within the range of $63.92–$80.57. His cross-ticker track record shows 1 prior sell with a 0.00% well-timed rate at the 90-day mark (meaning prior sales did not precede declines). At HSIC specifically, his single prior sale on 2023-05-24 returned +1.5% over 90 days post-transaction. The company shows a P/E of 29.26 against annual revenue growth of -2.4%, suggesting elevated valuation amid declining revenue.

SVP McGlynn sells 21,035 shares of HSIC at $69.30; stock at $68.89, down 14.5% from 52-week high

McGlynn Lorelei, SVP and Chief Human Resources Officer, sold 21,035 shares at $69.30 on 2024-09-06, reducing her holdings by 22.7% from 92,868 to 71,833 shares. The transaction occurred when HSIC was trading near its current level of $68.89, approximately 14.5% below its 52-week high of $80.57. The company's fundamentals show revenue of $3.1B in the latest quarter with annual revenue declining 2.4% year-over-year, and a P/E ratio of 24.78. This sale by a senior HR executive warrants monitoring given the combination of declining revenue growth and the material reduction in her equity position.